Crohn S Disease Program Ole
Research payments
$2,469,012
Through program year 2025, $2,469,012 in research payments was reported against Crohn S Disease Program Ole, across 1,293 payments, paid by Roche Products Limited.
- Paid by
- Roche Products Limited
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $20,441 | 13 |
| 2024 | Research | $279,842 | 150 |
| 2023 | Research | $137,871 | 152 |
| 2022 | Research | $419,276 | 179 |
| 2021 | Research | $605,993 | 268 |
| 2020 | Research | $531,692 | 291 |
| 2019 | Research | $473,895 | 240 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- George Duvall Tyler, TX Named on 68 payments
- Henry Levine Orlando, FL Named on 39 payments
- Edward Loftus Rochester, MN Named on 36 payments
- Timothy Ritter Southlake, TX Named on 36 payments
- Aasim Sheikh Marietta, GA Named on 32 payments
- Robin Dalal Nashville, TN Named on 25 payments
- Timothy Zisman Seattle, WA Named on 23 payments
- Shankar Thiruppathi Columbus, GA Named on 23 payments
- Kenneth Johnson Kinston, NC Named on 22 payments
- Marcus Muehlbauer Gainesville, FL Named on 20 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.